182 results on '"Sturkenboom, M C J M"'
Search Results
2. Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)
3. Fluoroquinolones And Risk Of Achilles Tendon Disorders: Case-Control Study
4. Letter: incidence rates of Barrettʼs oesophagus and oesophageal adenocarcinoma in UK and the Netherlands – authorsʼ reply
5. The incidence of Barrettʼs oesophagus and oesophageal adenocarcinoma in the United Kingdom and the Netherlands is levelling off
6. Prevalence and treatment of hypertensive patients with multiple concomitant cardiovascular risk factors in The Netherlands and Italy
7. Impact of risk minimisation measures on the use of strontium ranelate in Europe : a multi-national cohort study in 5 EU countries by the EU-ADR Alliance
8. Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance
9. Correction to:: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)
10. Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
11. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study
12. RISK OF LIVER INJURY IN PAEDIATRIC POPULATION: DATA MINING ON ELECTRONIC HEALTHCARE DATABASES IN EUROPE: P252
13. Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage
14. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
15. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
16. Referral and treatment patterns for complex regional pain syndrome in the Netherlands
17. Estrogens and the risk of complex regional pain syndrome (CRPS)
18. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patientsʼ modifiable risk factor profile
19. Gastro-oesophageal reflux, medical resource utilization and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma
20. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage
21. The role of pharmacists in the recruitment of a cohort for postmarketing surveillance: A case study of acitretin in the Netherlands
22. Persistence and adherence to proton pump inhibitors in daily clinical practice
23. Abstracts of papers
24. Communicating a drug alert: A case study on acitretin in The Netherlands
25. Abstracts of papers and posters Meeting on Pharmaceutical Sciences
26. Increasing incidence of Barrett’s oesophagus in the general population
27. Uptake of Angiotensin II Receptor Blockers in the treatment of hypertension
28. A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy
29. Acitretin (Neotigason®): A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways
30. Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons
31. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine
32. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs
33. Underutilization of preventive strategies in patients receiving NSAIDs
34. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events
35. Paediatric Acute Liver Injury: Signal Detection Using Multiple Healthcare Databases from the EU-ADR Network
36. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study
37. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine
38. Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD
39. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases
40. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
41. Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death
42. Intracranial aneurysm segmentation in 3D CT angiography: method and quantitative validation
43. Adherence to proton pump inhibitors or H 2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs
44. Correspondence
45. Multiple sclerosis and antecedent infections: A case-control study
46. Postmarketing Surveillance Based on Electronic Patient Records: The IPCI Project
47. Taste loss to terbinafine: a case-control study of potential risk factors
48. Differential effects of spermine and its analogues on the structures of polynucleotides complexed with ethidium bromide
49. Acitretin (Neotigason®)
50. Effect of polyamine depletion on chromatin structure in U-87 MG human brain tumour cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.